BTG Announces FDA Approval of Oral Contraceptive Incorporating BTG's Proprietary Dosing Regimen.
Business Wire › April 30, 1998
Linked as:
Extract
BTG Announces FDA Approval of Oral Contraceptive Incorporating BTG's Proprietary Dosing Regimen.
ISELIN, N.J--(BUSINESS WIRE)--April 30, 1998--Bio-Technology General Corp. (NASDAQ:BTGC) today announced that an oral contraceptive, incorporating BTG's patented dosing regimen licensed to an affiliate of Organon, Inc., has re...
See the full content of this document
Sponsored links
